EUVIMEDEUVIMED entdecken
Crossref

Varicella‐Zoster Virus Reactivation After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation, Single‐Center Experience of Acyclovir Prophylaxis

Galip Arıcı iD, Elif Ince iD, Erdal Ince iD, Talia Ileri iD, Ergin Ciftci iD, Figen Dogu iD, Halil Ozdemir iD, Hasan Fatih Cakmakli iD, Mehmet Ertem iD

Pediatric Transplantation · 2024

DOI: 10.1111/petr.14819 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Transplantation, 2024. Verfasst von Galip Arıcı und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Cardiology, Etlik City Hospital, Ankara, Turkey. Hauptthemen laut MEDLINE: Acyclovir, Hematopoietic Stem Cell Transplantation, Antiviral Agents, Virus Activation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Varicella‐zoster virus (VZV) reactivation is the most common infectious complication in the late posthematopoietic stem cell transplantation (HSCT) period and is reported as 16%–41%. Acyclovir prophylaxis is recommended for at least 1 year after HSCT to prevent VZV infections. However, studies on the most appropriate prophylaxis are ongoing in pediatric patients.

Methods

Patients who underwent allogeneic HSCT between January 1, 1996 and January 1, 2020 were retrospectively analyzed to outline the characteristics of VZV reactivation after allogeneic HSCT in pediatric patients using 6 months acyclovir prophylaxis.

Results

There were 260 patients and 273 HSCTs. Median age was 10.43 (0.47–18.38), and 56% was male. Median follow‐up was 2325 days (18–7579 days). VZV reactivation occurred in 21.2% ( n = 58) at a median of 354 (55–3433) days post‐HSCT. The peak incidence was 6–12 months post‐HSCT (43.1%). Older age at HSCT, female gender, history of varicella infection, lack of varicella vaccination, low lymphocyte, CD4 count, and CD4/CD8 ratio at 9 and 12 months post‐HSCT was found as a significant risk for herpes zoster (HZ) in univariate analysis, whereas history of varicella infection and low CD4/CD8 ratio at 12 months post‐HSCT was an independent risk factor in multivariate analysis.

Conclusions

Tailoring acyclovir prophylaxis according to pre‐HCT varicella history, posttransplant CD4 T lymphocyte counts and functions, and ongoing immunosuppression may help to reduce HZ‐related morbidity and mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcyclovirHematopoietic Stem Cell TransplantationAntiviral AgentsVirus ActivationHerpesvirus 3, HumanHumansMaleFemaleChildRetrospective StudiesChild, PreschoolAdolescentInfantHerpes ZosterVaricella Zoster Virus InfectionTransplantation, HomologousRisk Factors

Stichwörter der Autor:innen

acyclovir prophylaxishematopoietic stem cell transplantationherpes zostervaricella‐zoster virus

Substanzen

AcyclovirAntiviral Agents

Autor:innen und Institutionen

  • Department of Pediatric Cardiology, Etlik City Hospital, Ankara, Turkey.
  • Department of Pediatric Hematology, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Department of Pediatrics, Memorial Hospital, Ankara, Turkey.
  • Department of Pediatric Infection, Ankara University Faculty of Medicine, Ankara, Turkey.
  • Department of Pediatric Allergy and Immunology, Ankara University Faculty of Medicine, Ankara, Turkey.

ORCID-Profile: Galip Arıcı, Elif Ince, Erdal Ince, Talia Ileri, Ergin Ciftci, Figen Dogu, Halil Ozdemir, Hasan Fatih Cakmakli, Mehmet Ertem

Zitieren

APA

Arıcı, G., Ince, E., Ince, E., Ileri, T., Ciftci, E., Dogu, F., Ozdemir, H., Cakmakli, H. F., & Ertem, M. (2024). Varicella‐Zoster Virus Reactivation After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation, Single‐Center Experience of Acyclovir Prophylaxis. Pediatric Transplantation. https://doi.org/10.1111/petr.14819

Vancouver

Arıcı G, Ince E, Ince E, Ileri T, Ciftci E, Dogu F, et al. Varicella‐Zoster Virus Reactivation After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation, Single‐Center Experience of Acyclovir Prophylaxis. Pediatric Transplantation. 2024. doi:10.1111/petr.14819

BibTeX
@article{Arc2024,
  author = {Arıcı, Galip and Ince, Elif and Ince, Erdal and Ileri, Talia and Ciftci, Ergin and Dogu, Figen and Ozdemir, Halil and Cakmakli, Hasan Fatih and Ertem, Mehmet},
  title = {Varicella‐Zoster Virus Reactivation After Pediatric Allogeneic Hematopoietic Stem Cell Transplantation, Single‐Center Experience of Acyclovir Prophylaxis},
  journal = {Pediatric Transplantation},
  year = {2024},
  doi = {10.1111/petr.14819}
}
Kostenlos starten →